Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab

Monoclonal antibody (mAb) drugs have been widely used for treating tumor necrosis factor α (TNFα)-related diseases for over 10 years. Although their action has been hypothesized to depend in part on their ability to bind precursor cell surface TNFα, the precise mechanism and the epitope bound on TNF...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Liang, Shuaiyi, Dai, Jianxin, Hou, Sheng, Su, Lishu, Zhang, Dapeng, Guo, Huaizu, Hu, Shi, Wang, Hao, Rao, Zihe, Guo, Yajun, Lou, Zhiyong
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Biochemistry and Molecular Biology 2013
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650416/
https://ncbi.nlm.nih.gov/pubmed/23504311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.433961
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk